ANGUS Chemical creates life sciences division

Business Wire

BUFFALO GROVE - ANGUS Chemical Co., a manufacturer and marketer of nitroalkanes and their derivatives, has today launched a new life sciences division, ANGUS Life Sciences.

Formed to provide a dedicated focus on the specific needs of the life sciences industry, ANGUS Life Sciences supplies customers in the biotechnology, pharmaceutical and agriculture markets with the high-quality buffers, biochemicals, biomolecules and intermediates they have come to rely on.

"Our new ANGUS Life Sciences division is built on our rich, 70-year legacy of manufacturing specialized chemistries, such as our TRIS AMINO," said Mark Henning, President and CEO of ANGUS. "We understand the importance of aligning and controlling stability, consistency, quality and compliance across the duration of product lifecycles. This new business division is a testament to our commitment to our life sciences customers by providing premium fine and specialty chemistries they need to develop their best products for R&D, scale-up and production."

Based in the United States, ANGUS Life Sciences is the world's only fully integrated manufacturer of TRIS AMINO buffers, based on their unique nitroalkane chemistry. In addition to TRIS AMINO, ANGUS Life Sciences also provides other high-quality offerings, including biological buffers, biochemicals, biomolecules and amino acids.

"We're dedicated to what matters most to our customers - quality products, traceable and auditable supply chains, and optimized cost-effectiveness and efficiency. Through ANGUS Life Sciences, we strive to be an innovative partner to our customers within the life sciences industry," said Dave Green, Vice President of R&D at ANGUS. "We look forward to helping our customers develop winning products, conduct successful launches and achieve faster time-to-market."